Skip to content

Latest

Merck to acquire EyeBio

Merck to acquire EyeBio

Merck and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.

CVS looks for investor to back new Oak Street clinics

CVS looks for investor to back new Oak Street clinics

CVS Health is been seeking a private equity partner to fund growth at Oak Street Health, a primary care provider the chain purchased a year ago, Bloomberg News reported on Thursday. CVS has been working with financial advisers to help find capital to back new clinics that will be opened by Oak